Ovid Therapeutics Inc (OVID) Stock: A Year of Stock Market Ups and Downs


The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Ovid Therapeutics Inc’s current trading price is -79.81% away from its 52-week high, while its distance from the 52-week low is 22.91%. The stock’s price range for this period has been between $0.68 and $4.14 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.77 million for the day, a number notably lower than the average daily volume of 0.84 million over the last three months.

The market performance of Ovid Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $4.14 on 08/22/23, while the lowest value for the same duration was $0.68 on 06/26/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Ovid Therapeutics Inc (OVID) has experienced a quarterly decline of -74.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 59.29M and boasts a workforce of 40 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.8323, with a change in price of -3.2042. Similarly, Ovid Therapeutics Inc recorded 624,216 in trading volume during the last 100 days, posting a change of -79.31%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for OVID stands at 0.58. Similarly, the long-term debt-to-equity ratio is also 0.57.

OVID Stock Stochastic Average

As of today, Ovid Therapeutics Inc’s raw stochastic average for the last 50 days stands at 5.62%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 5.92%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 3.71% and 3.12%, respectively.

OVID Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -74.04% this year. Over the last six months, there has been a stronger performance of -73.55%. The price of OVID leaped by -72.86% during the last 30 days period. For the last 5-days stocks have improved 8.66%.

Most Popular